Michael Funk Chiappetta

Title: Innovations by Michael Funk Chiappetta in Therapeutic Delivery Systems

Introduction

Michael Funk Chiappetta is an innovative inventor based in Greenwood, IN, known for his contributions to the field of therapeutic fluid delivery systems. With a focus on enhancing the effectiveness of high-viscosity therapeutic fluids, his work has broad implications for medical treatments, particularly in delivering crucial protein therapeutics.

Latest Patents

Chiappetta holds one patent titled "Processes and devices for delivery of fluid by chemical reaction." This patent describes a novel approach to parenteral delivery systems which utilize chemical reactions to generate gas, effectively facilitating the delivery of therapeutic fluids. The device comprises three key components: a first actuation chamber with a first reagent, a second reaction chamber with a second reagent, and a therapeutic fluid chamber. The innovation allows a plunger to separate the first and second chambers in the loaded configuration, and upon actuation, enables the first reagent to react with the second, generating gas that ultimately delivers the therapeutic fluid.

Career Highlights

Currently, Michael Funk Chiappetta is associated with Eli Lilly and Company, a prominent player in the pharmaceutical industry. His efforts in developing advanced delivery systems have positioned him at the forefront of innovation in drug delivery technology. His patent serves as a testament to his expertise and commitment to improving therapeutic methodologies.

Collaborations

Chiappetta collaborates with a team of skilled professionals at Eli Lilly, including notable coworkers such as William Godwin Atterbury and Corrie Jo Bennison. These collaborations enhance the inventive process, combining diverse expertise to further refine and implement innovative medical solutions.

Conclusion

Michael Funk Chiappetta’s invention of processes and devices for therapeutic fluid delivery illustrates a significant advancement in medical technology. His contributions, along with effective teamwork at Eli Lilly and Company, continue to pave the way for more effective therapeutic interventions, showcasing the vital role of innovation in healthcare.